JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 18, 2006; DOI: 10.1124/jpet.106.113639


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.113639v1
320/3/1013    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKay, D. M.
Right arrow Articles by Lu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKay, D. M.
Right arrow Articles by Lu, J.


Received for publication September 11, 2006.
Revised December 14, 2006.
Accepted for publication December 15, 2006.

PI-3K is a critical mediator of interferon-{gamma}-induced increases in enteric epithelial permeability

Derek M. McKay 1*, James L. Watson 2, Arthur Wang 2, Jackie Caldwell 2, David Prescott 2, Peter M.J. Ceponis 2, Vincenza Di Leo 3, Jun Lu 2

1 Univeristy of Calgary 2 McMaster University 3 University Hospital Padova

* Address correspondence to: E-mail: dmckay{at}ucalgary.ca

Abstract

The epithelial lining of mucosal surfaces acts as a barrier to regulate the entry of antigen and pathogens. Nowhere is this function of the contiguous epithelium more important than in the gut which is continually exposed to a huge antigenic load and, in the colon, an immense commensal microbiota. We assessed the intracellular signalling events that underlie interferon-{gamma} (IFN{gamma})-induced increases in epithelial permeability using monolayers of the human colonic T84 epithelial cell line. Confluent epithelial monolayers on semi-permeable supports were treated with IFN{gamma} (20ng/ml), and barrier function assessed 48h later by measuring transepithelial electrical resistance (TER: reflects passive ion flux), fluxes of 51Cr-EDTA and horseradish peroxidase (HRP), and transcytosis of non-invasive, non-pathogenic Escherichia coli (strain HB101). Exposure to IFN{gamma} decreased barrier function as assessed by all 4 markers. The PI-3K inhibitors, LY294002 and wortmannin, did not affect baseline permeability characteristics, but completely blocked the drop in TER and increased fluxes of 51Cr-EDTA and HRP, and significantly reduced E. coli transcytosis evoked by IFN{gamma}. Also, use of the pan-PKC inhibitor, bisindolylmalemide I (5µM), but not rottlerin (blocks PKC{delta}), partially ameliorated the drop in TER and inhibited increased E. coli transcytosis. Addition of the PI-3K and PKC inhibitors to epithelia 6h after IFN{gamma} exposure still prevented the increase in paracellular permeability, but not E. coli transcytosis. Thus IFN{gamma}-induced increases in epithelial paracellular and transcellular permeability are critically dependent on PI-3K activity, which may represent an epithelial-specific target to treat immune-mediated loss of barrier function.


Key words: Signal transduction, bacterial transcytosis, human, intestine, protein kinase C, tight junction


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Kaur, A. Sassano, A. M. Joseph, B. Majchrzak-Kita, E. A. Eklund, A. Verma, S. M. Brachmann, E. N. Fish, and L. C. Platanias
Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling
J. Immunol., November 15, 2008; 181(10): 7316 - 7323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Lewis, J. Caldwell, V. Phan, D. Prescott, A. Nazli, A. Wang, J. D. Soderholm, M. H. Perdue, P. M. Sherman, and D. M. McKay
Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-{alpha}
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G669 - G678.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.